Open AccessWhole-gland ablation therapy versus active surveillance for low-risk prostate cancer: a prospective study
Author(s) -
Dmitry Enikeev,
Mark Taratkin,
А В Амосов,
Juan Gómez Rivas,
Alexei Podoinitsin,
Natalia V. Potoldykova,
Marina Karageziyan,
Petr Glybochko,
Éric Barret
Publication year - 2020
Publication title -
central european journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.403
H-Index - 20
eISSN - 2080-4873
pISSN - 2080-4806
DOI - 10.5173/ceju.2020.0009
Subject(s) - medicine , cryoablation , prostate cancer , brachytherapy , high intensity focused ultrasound , cryotherapy , clinical endpoint , prostate , ablation , urology , prospective cohort study , cryosurgery , biopsy , cancer , radiology , surgery , ultrasound , radiation therapy , clinical trial
The objective of this study is assess the outcomes of whole-gland ablation (high-intensity focused ultrasound (HIFU), cryotherapy and brachytherapy) and active surveillance (AS) in patients with low-risk prostate cancer (PCa).